Charles MacKinnon

Charles was formerly the Healthcare Director at IEG4 Ltd, the company behind CHC2DST’s digital Continuing Healthcare tool. Charles’ career has been focussed on delivering improvements for patients through roles in clinical research, medical communications, patient support and software development. Previously, he has led the communications strategy for the first long-acting Beta Agonist inhaler for asthma; led the launch of MS One to One, a global digital patient support resource for sufferers of Multiple Sclerosis; led the development of a global website for Urologist education; and worked as European Lead for global medical communications organisation, Omnicom Inc.